20 karma · joined January 29, 2020
Contact me if you want to see it applied to text based DL models, time series based DL models or Image based DL models.
Android also has the problem that users are far less likely to be as educated (since target audience is not white collar but blue collar) and far less likely to report problems, issues or malware. So I'd even take the reported values to be lower than what the actual case is.
Their processes and org structure is not built for that either with siloed teams. So much that quite often some teams will not know what kind of data is being collected by other teams even.
Most banks just copy each other.
Consider a sample size of 10/1million with height value of 7m. And somehow 7/10 had poor ability to repay loans. With such a small sample size of this relevant factor be a good thing to rely on?
Contrastive LRP would be a good starting point for you for generating high fidelity explanations at any point in the network.
You don’t need to reduce complexity to induce explainability. You just need to decompose the function into smaller parts which you can understand.
Contrastive LRP for example is a Function decomposition technique for explaining deep neural networks with high fidelity.
Finding something odd for an algorithm (especially a deep neural network) is hard because they fail in just so many ways. For example, lenet for mnist almost always gives high confidence predictions for random tensors(torch.randn). Most imagenet models fail in the presence of just 20-30% salt and pepper noise. (Both of these are problems solvable through simple preprocessing techniques)
So even when we do not understand the precise impact of drugs on humans and there is no safer mechanism to test, we leave only 0.5% of candidate molecules to empirical/statistical evidence in the form of clinical trials.
On the other hand if drug discovery was treated as a pure AI problem, we would have thousands of unverified and unsafe molecules in clinical trials.
Causal principles get us to 99.5% of the way in drug discovery. Unfortunately not so in AI.
And there is no reason to expect that a deep learning model has to be unexplainable. He’s putting up a mystical interpretability vs accuracy tradeoff which does not exist.
There is a ton of research out there making deep neural networks (slightly to significantly interpretable)
To him, all the precursors to clinical trials (selection of a molecule from restricted set of molecules which satisfy certain causal criteria) then followed by extensive multi million dollar experiments to safeguard the last 1-2% of uncertainty is equivalent to a barely preprocessed neural network.
I mean let’s ignore the basic principles of pharmacology and medicine and just run every possible molecule through humans since that is a valid approach according to him.